Practice and Exploration of Negotiation Drugs “ Double Channel” Closed-loop Management in Nanjing

China Health Insurance ›› 2022, Vol. 0 ›› Issue (5) : 75-78.

China Health Insurance ›› 2022, Vol. 0 ›› Issue (5) : 75-78. DOI: 10.19546/j.issn.1674-3830.2022.5.015
Management Platform

Practice and Exploration of Negotiation Drugs “ Double Channel” Closed-loop Management in Nanjing

Author information +
History +

Abstract

In order to improve availability and affordability of drugs, China has successively issued a series of new policies including the drug price zero-addition policy, the national volume-based procurement and national medical insurance negotiation drugs, continuously guaranteeing drug qualities and reducing medical burden. However, negotiation drugs fail to cross “the last kilometer” to enter the hospitals because local administration has difficulty in strengthening the coordination of the hospital and the medical insurance institution. Nanjing Healthcare Security Bureau is patient-centered and committed to ensuring the medical insurance benefit according to its own functions. Based on the people-oriented principle, dimensions of assurance, system improvement, process control, a closed-loop service management system with the coordination of all elements of the insured is established to solve the admission problem of negotiation drugs, providing Nanjing scheme for the full implementation of "double channel" of negotiation drugs.

Key words

double channel / double assurance / Nanjing / negotiation drugs

Cite this article

Download Citations
Practice and Exploration of Negotiation Drugs “ Double Channel” Closed-loop Management in Nanjing[J]. China Health Insurance. 2022, 0(5): 75-78 https://doi.org/10.19546/j.issn.1674-3830.2022.5.015

References

[1] 戴伟. 用市场思维引导谈判药品落地[J].中国社会保障,2021(08):27.
[2] 张钰婉,谈在祥,卢亚娟.国家谈判药品“双通道”模式实施现状及优化建议——以S市为例[J].卫生经济研究,2022,39(04):15-18+23.DOI:10.14055/j.cnki.33-1056/f.2022.04.004.
[3] 张博,丁锦希,陈烨,李伟.国家医保谈判药品“双通道”政策动因与实施模式[J].世界临床药物,2021,42(09):709-716.DOI:10.13683/j.wph.2021.09.001.
[4] 刁仁昌,卢旻,陈翀等.国家谈判药品落地南京的实践与思考[J].药学进展,2021,45(10):769-774.
[5] 郑登滋,李玉水,陈纯等.福建省推进国家谈判药品政策落地情况调研及实证分析——基于集中采购与特药药房数据[J].中国医疗保险,2021(10):30-35.DOI:10.19546/j.issn.1674-3830.2021.10.002.
[6] 南京市医疗保障局,南京市卫生健康委员会.关于建立完善国家医保谈判药品“双通道”管理机制的实施方案[N].宁医发〔2021〕70号.

Accesses

Citation

Detail

Sections
Recommended

/